SCHEMBL6955262

SCHEMBL6955262

COC(=O)CNc1nc(OCC(F)(F)F)c(C#N)c(N2CCc3ccccc3CC2)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 1/20 0.40
KDM4E B2RXH2 4/20 0.38
HPGD P15428 4/20 0.38
MAPT P10636 3/20 0.38
ALDH1A1 P00352 3/20 0.38
HSD17B10 Q99714 3/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
TP53 P04637 1/20 0.38
HTT P42858 1/20 0.38
MKNK1 Q9BUB5 1/20 0.36
MKNK2 Q9HBH9 1/20 0.36
TSHR P16473 3/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
PIK3CA P42336 1/20 0.35
PLK1 P53350 1/20 0.35
KHK P50053 2/20 0.34
GLA P06280 1/20 0.34
CYP1A2 P05177 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6952840 0.85 PIK3CD (0.38) PIK3CDKDM4EHPGDMAPTALDH1A1
SCHEMBL6949140 0.85 PLK1 (0.39) PIK3CDKDM4EHPGDMAPTALDH1A1
SCHEMBL6945704 0.85 GRIN2D (0.41) PIK3CDKDM4EHPGDMAPTALDH1A1
SCHEMBL6945718 0.84 ALDH1A1 (0.40) PIK3CDKDM4EHPGDMAPTALDH1A1
SCHEMBL6957130 0.82 IDH2 (0.39) PIK3CDKDM4EHPGDMAPTALDH1A1
SCHEMBL6951267 0.81 ALDH1A1 (0.40) PIK3CDKDM4EHPGDMAPTALDH1A1
SCHEMBL6948041 0.81 ABCC1 (0.41) PIK3CDKDM4EHPGDMAPTALDH1A1
SCHEMBL6956303 0.80 KDM4E (0.41) PIK3CDKDM4EHPGDMAPTALDH1A1
SCHEMBL6955488 0.79 AURKA (0.38) PIK3CDKDM4EHPGDMAPTALDH1A1
SCHEMBL6949377 0.79 MEN1 (0.42) KDM4EHPGDMAPTALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed